Literature DB >> 4414985

Parkinsonism and hyperthyroidism.

S Lavy, E S Marks, O Abramsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4414985     DOI: 10.1159/000114600

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  6 in total

1.  Graves' disease presenting as hemiparkinsonism.

Authors:  J S Davies; P K Morrish; M F Scanlon
Journal:  J Endocrinol Invest       Date:  2001-03       Impact factor: 4.256

2.  Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa.

Authors:  B Vergès; M Giroud; G Vaillant; B Verges-Patois; J M Brun; R Putelat
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

3.  Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment.

Authors:  T H Caradoc-Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-05

4.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

5.  Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.

Authors:  Ippolita Cantuti-Castelvetri; Ledia F Hernandez; Christine E Keller-McGandy; Lauren R Kett; Alex Landy; Zane R Hollingsworth; Esen Saka; Jill R Crittenden; Eduardo A Nillni; Anne B Young; David G Standaert; Ann M Graybiel
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

6.  A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in Mice.

Authors:  Li Zhang; Jin Wang; Aizhang Xu; Conghao Zhong; Wuguang Lu; Li Deng; Rongxiu Li
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.